ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
ADARx Pharmaceuticals's investors include BlackRock, Cormorant Asset Management, Vivo Capital, Lilly Asia Ventures, TCG Crossover.
ADARx Pharmaceuticals is headquartered in San Diego, United States.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
ADARx Pharmaceuticals is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ADARx Pharmaceuticals — Funding & Investors." VCBacked, February 1, 2025, https://www.vcbacked.co/company/adarx-pharmaceuticals. Accessed September 3, 2026.
VCBacked. (2025). ADARx Pharmaceuticals — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/adarx-pharmaceuticals
{{cite web |title=ADARx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/adarx-pharmaceuticals |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated